64 Episodio

  1. Navigating US payer evidence needs to optimise market access

    Pubblicato: 27/11/2024

  2. Best practice RWE approaches to support economic modelling for HTA

    Pubblicato: 20/11/2024

  3. NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas

    Pubblicato: 18/11/2024

  4. De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

    Pubblicato: 11/10/2024

  5. NHS primary care panel – the GP Contract and Operational Planning Guidance

    Pubblicato: 10/09/2024

  6. Engage NHS healthcare decision-makers with RWD

    Pubblicato: 12/08/2024

  7. Market access and reimbursement in Canada – changes at CADTH

    Pubblicato: 20/06/2024

  8. Rare Disease market access in the MENA and Nordic regions

    Pubblicato: 10/05/2024

  9. How does funding flow in NHSE Regions?

    Pubblicato: 09/04/2024

  10. NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)

    Pubblicato: 09/04/2024

  11. De-mystifying health economic model classifications and structures

    Pubblicato: 22/03/2024

  12. Evidence strategy for Medical Technologies and Diagnostics

    Pubblicato: 12/03/2024

  13. How to set your Pharma or Medtech product up for success in the US market

    Pubblicato: 26/02/2024

  14. What's happening with specialised commissioning in the NHS?

    Pubblicato: 12/02/2024

  15. Integrated care in NHS Wales – what can England learn from its neighbour?

    Pubblicato: 17/01/2024

  16. Market access in Italy: Reforms at AIFA

    Pubblicato: 18/12/2023

  17. Unmet need in NHS primary care – How can industry best support PCN leaders?

    Pubblicato: 28/11/2023

  18. Population health management: a community effort across health and life sciences

    Pubblicato: 01/11/2023

  19. Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access

    Pubblicato: 26/10/2023

  20. 6 areas of UK health policy for Medtech to pay attention to

    Pubblicato: 16/10/2023

1 / 4

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence. 

Visit the podcast's native language site